Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
657
Views
0
CrossRef citations to date
0
Altmetric
Rapid Communication

Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron era

Xian Lia Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaView further author information
,
Aiqi Zhaoa Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaView further author information
,
Huifang Jiangb Department of Hematology, TongDe Hospital of Zhejiang Province, Hangzhou, People’s Republic of ChinaView further author information
,
Ying Luc Department of Hematology, The Affiliated People’s Hospital of Ningbo University, Ningbo, People’s Republic of ChinaView further author information
,
Jing Led Department of Hematology, Ningbo Medical Center Li Huili Hospital, Ningbo, People’s Republic of ChinaView further author information
,
Yaping Xiee Department of Hematology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaView further author information
,
Meiwei Huf Department of Hematology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People’s Republic of ChinaView further author information
,
Hui Zengg Department of Hematology, The First Affiliated Hospital of Jiaxing University, Jiaxing, People’s Republic of ChinaView further author information
,
Jianzhi Zhaoh Department of Hematology, Shaoxing Center Hospital, Shaoxing, People’s Republic of ChinaView further author information
,
Mei Zhoui Department of Hematology, Zhuji People’s Hospital, Zhuji, People’s Republic of ChinaView further author information
,
Hui Zhouj Department of Hematology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, People’s Republic of ChinaView further author information
,
Lili Chenk Department of Medical Oncology, Taizhou First People’s Hospital, Taizhou, People’s Republic of ChinaView further author information
,
Weiguo Zhul Department of Hematology, Shaoxing Second Hospital, Shaoxing, People’s Republic of ChinaView further author information
,
Guifang Ouyangm Department of Hematology, Ningbo First Hospital, Ningbo, People’s Republic of ChinaView further author information
,
Huiqing Qiun Department of Hematology and Medical Oncology, The Second People’s Hospital of Quzhou, Quzhou, People’s Republic of ChinaView further author information
,
Songfu Jiango Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Qunyi Guop Department of Hematology and Medical Oncology, Enze Medical Center, Taizhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Wenbin Qiana Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Yun Lianga Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2288477 | Received 05 Sep 2023, Accepted 14 Nov 2023, Published online: 01 Dec 2023

References

  • He W, Chen L, Chen L, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34(6):1637–1645. doi:10.1038/s41375-020-0836-7
  • Meo SA, Meo AS, Al-Jassir FF, et al. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. Eur Rev Med Pharmacol Sci. 2021;25(24):8012–8018. doi:10.26355/eurrev_202112_27652
  • Ribera JM, Morgades M, Coll R, et al. Frequency, Clinical characteristics and outcome of adults with acute lymphoblastic leukemia and COVID 19 infection in the first vs. second pandemic wave in Spain. Clin Lymphoma Myeloma Leuk. 2021;21(10):e801–e809. doi:10.1016/j.clml.2021.06.024
  • Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881–2892. doi:10.1182/blood.2020008824
  • China CDC. COVID-19 clinical and surveillance data — December 9, 2022 to January 23, 2023, China. China CDC Weekly, 2023. https://weekly.chinacdc.cn/news/covid-surveillance/bfa0d054-d5bf-42bb-b8b4-f7ce34539b74_en.htm.
  • COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. [cited 2023 Feb 14]. Available from: https://www.covid19treatmentguidelines.nih.gov/.
  • Wood WA, Neuberg DS, Thompson JC, et al. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub. Blood Adv. 2020;4(23):5966–5975. doi:10.1182/bloodadvances.2020003170
  • García-Suárez J, de la Cruz J, Cedillo Á, et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol. 2020;13(1):133. doi:10.1186/s13045-020-00970-7
  • Palanques-Pastor T, Megías-Vericat JE, Martínez P, et al. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. Leuk Lymphoma. 2021;62(12):2928–2938. doi:10.1080/10428194.2021.1948031
  • Chari A, Samur MK, Martinez-Lopez J, et al. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set. Blood. 2020;136(26):3033–3040. doi:10.1182/blood.2020008150
  • Cook G, John Ashcroft A, Pratt G, et al. United Kingdom Myeloma Forum. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. Br J Haematol. 2020;190(2):e83–e86. doi:10.1111/bjh.16874
  • Meng B, Abdullahi A, Ferreira IATM, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603(7902):706–714. doi:10.1038/s41586-022-04474-x
  • Shuai H, Chan JF, Hu B, et al. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5. EBioMedicine. 2023 Sep;95:104753. doi:10.1016/j.ebiom.2023.104753
  • Blennow O, Salmanton-García J, Nowak P, et al. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report. Am J Hematol. 2022;97(8):E312–E317. doi:10.1002/ajh.26626
  • Goubet AG, Dubuisson A, Geraud A, et al. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death Differ. 2021;28(12):3297–3315. doi:10.1038/s41418-021-00817-9
  • Al Kaabi N, Zhang Y, Xia S, et al. Effect of 2 Inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 Infection in adults: a randomized clinical trial. JAMA. 2021 Jul 6;326(1):35–45. doi:10.1001/jama.2021.8565
  • Greenberger LM, Saltzman LA, Senefeld JW, et al. Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies. Cancer Cell. 2021;39(10):1297–1299. doi:10.1016/j.ccell.2021.09.001
  • Jondreville L, D'Aveni M, Labussière-Wallet H, et al. Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC. J Hematol Oncol. 2022;15(1):169. doi:10.1186/s13045-022-01387-0
  • Marasco V, Piciocchi A, Candoni A, et al. Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: the GIMEMA EMATO-0321 study. Br J Haematol. 2022;199(1):54–60. doi:10.1111/bjh.18385

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.